FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹4.70 Cr | ₹4.53 Cr | ₹4.43 Cr | ₹3.99 Cr | ₹3.99 Cr |
| Equity - Authorised | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹10.00 Cr |
| Equity - Issued | ₹4.70 Cr | ₹4.53 Cr | ₹4.43 Cr | ₹3.99 Cr | ₹3.99 Cr |
| Equity Paid Up | ₹4.70 Cr | ₹4.53 Cr | ₹4.43 Cr | ₹3.99 Cr | ₹3.99 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹1.57 Cr | ₹8.33 Cr | ₹0.21 Cr | - | - |
| Total Reserves | ₹115 Cr | ₹84 Cr | ₹63 Cr | ₹39 Cr | ₹37 Cr |
| Securities Premium | ₹71 Cr | ₹55 Cr | ₹45 Cr | ₹27 Cr | ₹27 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹44 Cr | ₹29 Cr | ₹18 Cr | ₹12 Cr | ₹10 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹115 Cr | ₹84 Cr | ₹63 Cr | ₹39 Cr | ₹37 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹121 Cr | ₹96 Cr | ₹68 Cr | ₹43 Cr | ₹41 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹13 Cr | ₹15 Cr | ₹42 Cr | ₹29 Cr | ₹11 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹9.25 Cr | ₹13 Cr | ₹42 Cr | ₹29 Cr | ₹11 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹3.55 Cr | ₹2.82 Cr | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr | ₹0.94 Cr |
| Deferred Tax Assets | - | - | - | - | - |
| Deferred Tax Liability | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr | ₹0.94 Cr |
| Other Long Term Liabilities | - | - | - | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹2.37 Cr | ₹1.96 Cr | ₹1.71 Cr | ₹1.61 Cr | ₹1.63 Cr |
| Total Non-Current Liabilities | ₹19 Cr | ₹21 Cr | ₹45 Cr | ₹32 Cr | ₹14 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹63 Cr | ₹59 Cr | ₹49 Cr | ₹60 Cr | ₹46 Cr |
| Sundry Creditors | ₹63 Cr | ₹59 Cr | ₹49 Cr | ₹60 Cr | ₹46 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹12 Cr | ₹8.32 Cr | ₹12 Cr | ₹15 Cr | ₹14 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹1.69 Cr | ₹1.13 Cr | ₹0.91 Cr | ₹5.14 Cr | ₹6.28 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹9.89 Cr | ₹7.19 Cr | ₹11 Cr | ₹9.70 Cr | ₹7.51 Cr |
| Short Term Borrowings | ₹87 Cr | ₹68 Cr | ₹11 Cr | ₹11 Cr | ₹23 Cr |
| Secured ST Loans repayable on Demands | ₹80 Cr | ₹64 Cr | ₹3.19 Cr | ₹7.57 Cr | ₹20 Cr |
| Working Capital Loans- Sec | ₹80 Cr | ₹64 Cr | ₹3.19 Cr | ₹7.57 Cr | ₹20 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-74 Cr | ₹-61 Cr | ₹4.36 Cr | ₹-4.61 Cr | ₹-16 Cr |
| Short Term Provisions | ₹5.54 Cr | ₹4.29 Cr | ₹2.79 Cr | ₹1.13 Cr | ₹2.57 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹5.54 Cr | ₹4.29 Cr | ₹2.79 Cr | ₹1.13 Cr | ₹2.57 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | - | - | - | - | - |
| Total Current Liabilities | ₹167 Cr | ₹140 Cr | ₹74 Cr | ₹86 Cr | ₹86 Cr |
| Total Liabilities | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr | ₹141 Cr |
| ASSETS | |||||
| Gross Block | ₹63 Cr | ₹52 Cr | ₹42 Cr | ₹38 Cr | ₹37 Cr |
| Less: Accumulated Depreciation | ₹16 Cr | ₹13 Cr | ₹9.80 Cr | ₹7.64 Cr | ₹5.64 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹47 Cr | ₹39 Cr | ₹32 Cr | ₹30 Cr | ₹31 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | - | - | - | - | - |
| Non Current Investments | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Long Term Investment | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Long Term Loans & Advances | ₹3.36 Cr | ₹2.13 Cr | ₹2.00 Cr | ₹1.18 Cr | ₹1.08 Cr |
| Other Non Current Assets | ₹0.46 Cr | - | - | - | - |
| Total Non-Current Assets | ₹50 Cr | ₹41 Cr | ₹34 Cr | ₹32 Cr | ₹32 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹0.81 Cr | ₹0.31 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.05 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.81 Cr | ₹0.31 Cr | ₹0.06 Cr | ₹0.06 Cr | ₹0.05 Cr |
| Inventories | ₹175 Cr | ₹150 Cr | ₹46 Cr | ₹68 Cr | ₹50 Cr |
| Raw Materials | ₹81 Cr | ₹64 Cr | ₹21 Cr | ₹36 Cr | ₹24 Cr |
| Work-in Progress | ₹57 Cr | ₹38 Cr | ₹13 Cr | ₹7.50 Cr | ₹9.28 Cr |
| Finished Goods | ₹20 Cr | ₹15 Cr | ₹3.27 Cr | ₹8.49 Cr | ₹7.89 Cr |
| Packing Materials | ₹18 Cr | ₹32 Cr | ₹9.07 Cr | ₹15 Cr | ₹9.17 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹65 Cr | ₹35 Cr | ₹90 Cr | ₹41 Cr | ₹39 Cr |
| Debtors more than Six months | ₹12 Cr | ₹14 Cr | ₹6.95 Cr | ₹2.07 Cr | - |
| Debtors Others | ₹53 Cr | ₹21 Cr | ₹83 Cr | ₹39 Cr | ₹39 Cr |
| Cash and Bank | ₹1.35 Cr | ₹3.44 Cr | ₹2.07 Cr | ₹1.13 Cr | ₹3.06 Cr |
| Cash in hand | ₹0.44 Cr | ₹0.50 Cr | ₹0.55 Cr | ₹0.38 Cr | ₹1.77 Cr |
| Balances at Bank | ₹0.91 Cr | ₹2.94 Cr | ₹1.53 Cr | ₹0.75 Cr | ₹1.29 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹1.44 Cr | ₹0.75 Cr | ₹0.58 Cr | ₹0.36 Cr | ₹0.29 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | - | - | - | - | - |
| Other current_assets | ₹1.44 Cr | ₹0.75 Cr | ₹0.58 Cr | ₹0.36 Cr | ₹0.29 Cr |
| Short Term Loans and Advances | ₹14 Cr | ₹27 Cr | ₹13 Cr | ₹20 Cr | ₹16 Cr |
| Advances recoverable in cash or in kind | ₹3.40 Cr | ₹13 Cr | ₹0.76 Cr | ₹0.79 Cr | ₹2.04 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹10 Cr | ₹15 Cr | ₹12 Cr | ₹19 Cr | ₹14 Cr |
| Total Current Assets | ₹257 Cr | ₹216 Cr | ₹153 Cr | ₹130 Cr | ₹109 Cr |
| Net Current Assets (Including Current Investments) | ₹90 Cr | ₹77 Cr | ₹79 Cr | ₹44 Cr | ₹23 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹308 Cr | ₹257 Cr | ₹187 Cr | ₹162 Cr | ₹141 Cr |
| Contingent Liabilities | - | - | - | - | - |
| Total Debt | ₹106 Cr | ₹87 Cr | ₹53 Cr | ₹40 Cr | ₹35 Cr |
| Book Value | 255.15 | 194.27 | 153.07 | 107.96 | 103.57 |
| Adjusted Book Value | 255.15 | 194.27 | 153.07 | 107.96 | 103.57 |
Compare Balance Sheet of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹788.6 Cr | 6.5% | 36.6% | 119.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 6.5% |
36.6% |
119.4% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses